CTSB and acute kidney injury: As expected, western blot analysis showed that AAV-CHMP4A markedly decreased CTSB, NBR1, SQSTM1 and LC3-II by western blot (Figure 8E–I), suggesting an improvement in lysosomal function in cisplatin-induced AKI.